124 related articles for article (PubMed ID: 36781369)
1. A new prognostic model for brain metastases of specific primary tumors with stereotactic radiotherapy.
Gu L; Qing S; Zhang HJ
Cancer Radiother; 2023 May; 27(3):183-188. PubMed ID: 36781369
[TBL] [Abstract][Full Text] [Related]
2. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
4. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
5. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
[TBL] [Abstract][Full Text] [Related]
6. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.
Johung KL; Yeh N; Desai NB; Williams TM; Lautenschlaeger T; Arvold ND; Ning MS; Attia A; Lovly CM; Goldberg S; Beal K; Yu JB; Kavanagh BD; Chiang VL; Camidge DR; Contessa JN
J Clin Oncol; 2016 Jan; 34(2):123-9. PubMed ID: 26438117
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
8. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
Zindler JD; Jochems A; Lagerwaard FJ; Beumer R; Troost EGC; Eekers DBP; Compter I; van der Toorn PP; Essers M; Oei B; Hurkmans CW; Bruynzeel AME; Bosmans G; Swinnen A; Leijenaar RTH; Lambin P
Radiother Oncol; 2017 May; 123(2):189-194. PubMed ID: 28237400
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery.
Gao HX; Huang SG; Du JF; Zhang XC; Jiang N; Kang WX; Mao J; Zhao Q
Int J Biol Sci; 2018; 14(14):2065-2072. PubMed ID: 30585269
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.
Cabanie C; Biau J; Durando X; Mansard S; Molnar I; Chassin V; Verrelle P; Khalil T; Lapeyre M; Dupic G
Cancer Radiother; 2021 Jul; 25(5):432-440. PubMed ID: 33836954
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
13. Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001.
Churilla TM; Handorf E; Collette S; Collette L; Dong Y; Aizer AA; Kocher M; Soffietti R; Alexander BM; Weiss SE
Ann Oncol; 2017 Oct; 28(10):2588-2594. PubMed ID: 28961826
[TBL] [Abstract][Full Text] [Related]
14. Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: Analysis of clinical and dosimetric data from a retrospective cohort of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Cox DG; Bund C; Antoni D; Cebula H; Noel G
Cancer Radiother; 2022 Sep; 26(5):692-702. PubMed ID: 35715354
[TBL] [Abstract][Full Text] [Related]
15. Radiosurgery for brain metastases from primary lung carcinoma.
Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population.
Holub K; Louvel G
Clin Transl Oncol; 2021 Jul; 23(7):1463-1473. PubMed ID: 33464481
[TBL] [Abstract][Full Text] [Related]
17. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis.
Gu L; Qing S; Zhu X; Ju X; Cao Y; Jia Z; Shen Y; Cao F; Fang F; Zhang H
Front Oncol; 2019; 9():1352. PubMed ID: 31921625
[No Abstract] [Full Text] [Related]
19. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
